Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma
Cancer Medicine · 2024
DOI: 10.1002/cam4.6961 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Cancer Medicine, 2024. Verfasst von Baoli Jin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Youth Foundation of Health Commission of Shanxi Province, the Shanxi Province Basic Applied Research Project, the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province.
Abstract (Originalsprache)
Background
To examine standardized uptake value max of the primary lesion (pSUVmax) and tumor markers (TMs) for clinically predicting distant metastasis in novo lung adenocarcinoma.
Methods
The current retrospective observational study examined individuals diagnosed with de novo lung adenocarcinoma at Shanxi Cancer Hospital between February 2015 and December 2019.
Results
Totally, 532 de novo lung adenocarcinoma cases were included. They were aged 60.8 ± 9.7 years and comprised 224 women and 268 patients with distant metastasis. The areas under the curves (AUCs) of pSUVmax, lactate dehydrogenase (LDH), carcinoembryonic antigen (CEA), cytokeratin‐19 fragment (CYFRA21‐1), carbohydrate antigen 125 (CA125), and Grade of TMs for predicting distant metastasis were 0.742, 0.601, 0.671, 0.700, 0.736, and 0.745, respectively. The combination of pSUVmax, LDH, CEA, CYFRA21‐1, CA125, and grade of TMs in predicting distant metastasis had an AUC value of 0.816 (95%CI: 0.781–0.851), with sensitivity of 89.2%, specificity of 58.7%, positive predictive value of 73.7%, and negative predictive value of 79.7%, respectively. Conclusions pSUVmax combined with serum levels of LDH, CEA, CYFRA21‐1, CA125, and the grade of TMs may have good performance in predicting distant metastasis of de novo lung adenocarcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, Ch…
- Department of Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Department of Surgery, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Shanxi Bethune Hospital, Taiyuan, Shanxi, China.
- Department of Administration, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Department of MR/CT, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Xiaolu Ren
Förderung
- Youth Foundation of Health Commission of Shanxi Province
- the Shanxi Province Basic Applied Research Project
- the Fund Program for the Scientific Activities of Selected Returned Overseas Professionals in Shanxi Province
Zitieren
APA
Jin, B., Wen, X., Tian, H., Guo, H., Hao, M., Wu, J., Li, X., Ren, Y., Wang, X., & Ren, X. (2024). Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma. Cancer Medicine. https://doi.org/10.1002/cam4.6961
Vancouver
Jin B, Wen X, Tian H, Guo H, Hao M, Wu J, et al. Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma. Cancer Medicine. 2024. doi:10.1002/cam4.6961
BibTeX
@article{Jin2024,
author = {Jin, Baoli and Wen, Xiaolian and Tian, Hanji and Guo, Hongxia and Hao, Mingyan and Wu, Jing and Li, Xiaomin and Ren, Yuejun and Wang, Xin and Ren, Xiaolu},
title = {Standardized uptake value max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.6961}
}
EUVIMED